Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Reliability and Performance Analysis of the Use of Tissue Flossing for Blood Flow Restriction.

NCT: NCT06075901 · ENROLLING_BY_INVITATION

NCT IDNCT06075901
StatusENROLLING_BY_INVITATION
Start Date2025-08-01
SponsorPaulista University (OTHER)
First posted
Last updated

Brief Summary

Blood flow restriction (RFS) is a widely studied technique that combines low-intensity exercise with vascular occlusion, resulting in muscular benefits. However, its application is challenging due to methodological variations and equipment costs. Tissue Flossing (TF) appears as an affordable alternative, but lacks solid scientific evidence.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑